Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.9M Sell
7,830,100
-1,615,800
-17% -$4.62M 6.15% 5
2025
Q4
$23.3M Sell
9,445,900
-1,599,800
-14% -$3.81M 5.05% 7
2025
Q3
$24.6M Buy
11,045,700
+590,000
+6% +$1.35M 4.94% 7
2025
Q2
$25.2M Sell
10,455,700
-905,800
-8% -$2.2M 5.07% 8
2025
Q1
$26.5M Sell
11,361,500
-1,396,800
-11% -$2.79M 5.05% 8
2024
Q4
$23.6M Buy
12,758,300
+577,800
+5% +$1.28M 3.9% 9
2024
Q3
$29.7M Sell
12,180,500
-2,395,400
-16% -$5.37M 4.04% 9
2024
Q2
$29.9M Buy
14,575,900
+4,407,800
+43% +$10M 3.62% 9
2024
Q1
$24.6M Buy
10,168,100
+4,300,000
+73% +$11.2M 2.27% 20
2023
Q4
$16.4M Buy
5,868,100
+4,115,300
+235% +$11.1M 1.26% 30
2023
Q3
$4.52M Buy
+1,752,800
New +$5.07M 0.36% 37

Other funds holding ABEV

Kiltearn Partners's ABEV Position: Q1 2026 in Review

Kiltearn Partners reduced its Ambev (ABEV) stake by 17% in Q1 2026, selling an estimated $4.62M and leaving 7,830,100 shares worth $22.9M. The position accounts for 6.15% of the portfolio, ranked #5.

Kiltearn Partners first reported a position in ABEV in Q3 2023 and has held it in 11 quarters since. The position peaked at $29.9M in Q2 2024. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Kiltearn Partners held 7,830,100 shares of Ambev worth $22.9M as of Q1 2026.
  • Kiltearn Partners sold 1,615,800 Ambev shares in Q1 2026, an estimated $4.62M.
  • Ambev made up 6.15% of Kiltearn Partners's portfolio in Q1 2026, its #5 holding.
  • Kiltearn Partners first reported a position in Ambev in Q3 2023 and has held it in 11 quarters since.
  • Kiltearn Partners's Ambev position peaked at $29.9M in Q2 2024.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.